Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3-day vs 5-day Amoxicillin in Uncomplicated Community Acquired Pneumonia in Children
NCT07647835Phase 1Not yet recruiting
- Sponsor
- Khyber Teaching Hospital
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of amoxicillin in community acquired pneumonia (CAP) (2 arms), sponsored by Khyber Teaching Hospital. Primary endpoints: Clinical Cure at 14 days and Treatment Failure at 5 days. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
amoxicillin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT07647835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07647835.